Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Stoke Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of STOK: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders9790−7
Shares20.2M19.4M−861.3K (−4.3%)
Value$680.3M$492.4M−$187.9M (−27.6%)

New holders (8)

Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to STOK in Q3 2021
InstitutionSharesValue% of portfolio
Tekla Capital Management LLC99,263$2.52M0.08%
Millennium Management LLC54,825$1.40M0.00%
HighVista Strategies LLC47,594$1.21M0.80%
Norges Bank45,200$1.15M0.00%
Cowen and Company, LLC35,899$913.0K0.04%
Gsa Capital Partners LLP9,753$248.0K0.03%
Healthcare of Ontario Pension Plan Trust Fund5,100$130.0K0.00%
Signaturefd, LLC33$1.00K0.00%

Sold out (15)

Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of STOK in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Perceptive Advisors LLC671,978$22.6M
Sphera Funds Management Ltd.233,135$7.85M
Bailard, Inc.43,300$1.46M
PDT Partners, LLC25,554$860.0K
Jump Financial, LLC10,200$343.0K
Trexquant Investment LP8,949$301.0K
Principal Financial Group Inc8,365$282.0K
D. E. Shaw & Co., Inc.7,143$240.0K
State Board of Administration of Florida Retirement System6,593$222.0K
Squarepoint Ops LLC6,495$219.0K
XTX Topco Ltd6,422$216.0K
Amundi5,300$178.0K
Point72 Hong Kong Ltd1,363$46.0K
FFT Wealth Management LLC300$10.0K
Toth Financial Advisory Corp60$2.00K